Hot Off the Press: Latest Sign-Ups
Just Confirmed to Attend
- Daiichi Sankyo
- Regeneron Pharmaceuticals
- IDEAYA Biosciences, Inc.
- Gilead Sciences
- BioNTech
- Bristol Myers Squibb
Teams Attending
- Immunome 15
- Astellas Pharma 13
- Daiichi Sankyo 15
- Amgen 12
- Bristol Myers Squibb 12
- Pfizer 26
Senior Decision-Makers Joining Daily
Latest confirmed job titles include:
- Vice President, ADC Development & Manufacturing
- Chief Executive Officer
- Scientific Associate
- Director
- Director, Antibody Development
- Vice President, Chemistry ADC
Real-Time Industry Participation Trends
And More...
Find Your Place in the ADC Ecosystem
No two attendees come to World ADC San Diego for the same reason, but that’s exactly what makes the room so powerful. From first-time entrants to seasoned industry leaders, these are the types of personas you can expect to meet. Explore where you fit, and who you’ll be connecting with onsite.
Long-Standing Attendee (Industry Anchor)
Senior ADC leaders, experienced scientists, and long-term industry participants who have attended the meeting consistently over multiple years. They are well embedded within the ADC community and view the event as a central touchpoint in their annual calendar.
Expectations:
High-quality, forward-looking content and the presence of key industry players. They are less interested in foundational material and more focused on differentiation, innovation, and strategic insight.
First-Time Attending Company (New Entrant / Market Explorer)
Companies entering the ADC space for the first time, including early-stage biotechs, start-ups, or organizations pivoting from adjacent areas such as biologics, antibodies, or small molecules.
Expectations:
Accessible, end-to-end content that provides both education and practical application, alongside opportunities to engage directly with service providers and experienced organizations.
Small Group Attendee (Focused Builder)
Small-to-mid-sized biotech teams actively developing ADC assets. Typically attending with a lean but carefully selected group of senior representatives across functions such as biology, chemistry, manufacturing, and business development.
Expectations:
Clear return on investment through high-value meetings, relevant scientific content, and efficient use of time across both learning and partnering activities.
Large Group Attendee
(Scale Player)
Large pharmaceutical or well-established biotech organizations with significant investment in ADCs. These companies typically send cross-functional teams, including both senior leadership and junior scientists.
Expectations:
A broad and deep scientific program that supports varied roles and expertise levels, alongside extensive networking opportunities with other leading organizations.
Business Development & Partnerships Lead (Deal-Maker)
Senior professionals in business development, licensing, corporate strategy, and investment roles, focused on identifying and advancing partnership opportunities within the ADC ecosystem.
Expectations:
Access to a strong attendee base of relevant stakeholders, structured and informal networking opportunities, and clear visibility of participating organizations.
Technical Specialist
(Deep Scientist)
Subject-matter experts working in specialised areas such as conjugation, linker technology, payload development, pharmacology, or tumour biology. Typically mid-to-senior level scientists seeking depth over breadth.
Expectations:
Highly technical sessions, detailed data presentations, and opportunities for peer-to-peer exchange, particularly through posters and niche tracks.
Emerging Talent (Next-Generation Attendee)
Early-career scientists or professionals new to the ADC field, often attending as part of a broader team from larger organizations.
Expectations:
Clear, structured content that supports learning, along with opportunities to observe and engage with more experienced colleagues and industry leaders.
Explore the Full 4-Day Experience
- 1,300+ Industry Attendees
- 400+ Attending Companies
- 170+ World-Class Speaker Faculty
- 17 Hours of Structured & Spontaneous Networking
- 7 Tracks of End-to-End ADC Content
- The World’s Largest & Definitive ADC Forum
Explore the Agenda
Hear the latest industry insights and discover cutting-edge, end-to-end ADC content from early discovery to late-stage manufacturing.
Partner With Us
Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma deals.
Join Biopharma Experts
Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.